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Introduction
Racial disparities in orthotopic heart transplantation (OHT) are well established. [1] [2] [3] [4] [5] [6] Several large-cohort analyses using the United Network for Organ Sharing (UNOS) database have demonstrated that amongst racial groups, blacks in particular are at higher risk of mortality following OHT. 1, 5, 6 The reasons for this discrepancy remain incompletely understood.
Several contributing factors may include late biologic influences, racial differences between donors and recipients in addition to higher degrees of sensitization and rates of graft failure among blacks as compared to other races. 4 Immunologic differences including more genetic mismatch and psychosocial factors such as adherence and willingness to seek medical attention for early warning signs of rejection or infection may also be important. In addition to these potential etiologies, there may be systems related issues as well. Blacks may not have access to postoperative care and immunosuppressive medications, with possibly fewer resources due to socioeconomic reasons.
Of unique interest is the performance of transplant centers where blacks receive their care. Center performance is of interest due to the relatively fixed number of OHTs in the United
States each year. Identification and implementation of measures aimed to improve center performance and/or regionalization of care to better performing centers are currently being debated as a means to improve nationwide outcomes of OHT. In this study, we evaluated the propensity of minorities to be transplanted at worse performing centers. In addition, we examined if there exists an increased risk of mortality in minority OHT recipients with particular attention to whether racial disparities in outcomes of OHT are preserved across the center performance spectrum.
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Methods

Data Source
The data source for the study was the UNOS registry. This dataset provides patient-level variables on all solid organ transplants in the United States. Because the database is publically available and de-identified, the institutional review board granted the study exempt status.
Study Cohort
Adults ( 18 years) undergoing cardiac transplantation between January 1, 2000 and December 31, 2010 were identified. Patients who underwent heterotopic (n=22), multivisceral (n=565), or redo heart transplantation (n=559) were excluded. These exclusions were done because the risk indices that were utilized in this study were developed from patients undergoing primary, singleorgan OHT and we wanted to create a similar study population to avoid confounding. Patients transplanted at centers that performed less than 50 total OHTs over the 10-year study period were also excluded (n=558) as limited conclusions could be drawn from centers performing few transplants.
Data Analysis
OHT recipients were primarily stratified by race. The primary outcome was all-cause 1-year mortality following OHT. Observed-to-expected mortality ratios (OEs) were calculated for each center. The expected mortality was derived using previously validated risk indices for recipient and donor risk in OHT. For recipient risk, the Index for Mortality Prediction After Cardiac Transplantation, or IMPACT score, was utilized (Appendix 1). 6 The IMPACT score is a 50-point scoring system that incorporates 12 recipient-specific risk factors. It has been validated as a highly predictive risk score for estimating 1-year mortality following OHT. [7] Importantly, race is incorporated in the IMPACT score, with blacks receiving 3 points for added mortality risk.
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For donor risk, a previously derived and validated 15-point score incorporating 4 donorrelated variables was used (Appendix 2). 8, 9 The recipient and donor risk score was calculated for each OHT recipient. The average IMPACT score and donor risk score at the center level was then determined by calculating the mean scores of all recipients and their respective donors at that center. The expected mortality based on recipient risk was then calculated by inputting the average IMPACT score of recipients at a center into the following equation which was previously derived: estimated 1-year mortality = (e^(0.13 x IMPACT) -2.75) / (1 + (e^(0.13 x IMPACT) -2.75)). 6 The expected mortality based on donor risk was calculating by inputting the average donor risk score of donors at a center into the following equation, which was generated from the predictive model in the original UNOS cohort: estimated 1-year mortality = 10.024 x (e^(0.0847 x donor risk score)). 8 Because these risk indices have similar predictive power in estimating 1-year mortality after OHT, the expected mortalities at the center level were calculated by averaging the estimated 1-year mortalities based on the mean recipient and donor risk scores for the patients at that center. The OE ratio for each center was calculated by dividing the actual 1-year mortality rate at that center by the average expected 1-year mortality.
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Results
Study Cohort
A total of 18,710 adult patients were identified as having undergone first-time, single-organ OHT during the study period. Of these, 18,085 were white (73.0%; n=13,657), black (16.4%; n=3,069), or Hispanic (7.3%; n=1,359). The remaining 625 (3.3%) were other races or unknown races and therefore excluded. The OHTs included in the analysis were performed at 102 unique transplant centers.
There were significant differences in recipient characteristics between races ( Table 1) .
Blacks were younger, had a higher proportion of females, a higher average serum creatinine, a higher percentage of UNOS status 1, and more idiopathic dilated cardiomyopathy. Overall, blacks had a higher IMPACT score which was expected given that black race alone is assigned 3 additional points in the risk index.
Blacks had the lowest proportion of blood type matching and human leukocyte antigen matching ( Table 1 ). Blacks and Hispanics had similar duration on the waitlist and ischemic times, both of which were significantly lower than observed in the white cohort. On average,
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blacks were transplanted at centers with lower OHT volumes. Overall, blacks had the highest mean donor risk index.
Recipient Mortality
Overall, there were 4,544 (25.2%) deaths at a mean follow-up of 3.8 ± 3.0 years. Table 2) . The same findings were demonstrated when individual components of the recipient and donor risk scores were used as covariates as opposed to the composite scores (Appendix 3).
Of the other risk factors for 1-year mortality, there were several that were found in higher proportions in black recipients that may in part explain their higher mortality risk, including a higher percentage of females, higher serum creatinine, higher proportion bridged with ventricular assist devices, and a higher percentage with recipient-donor race mismatching, although the effect of race on mortality risk was found to persist after adjusting for these confounders. When other variables that could be associated with race were forced into the multivariable model, including blood-type mismatch, human leukocyte mismatch, primary payer status, and education level of the recipient, only Medicaid or Medicare insurance status was found to be an additional risk factor for mortality. Although blacks comprised the highest percentage of Medicare beneficiaries, Hispanics represented the highest percentage of Medicaid beneficiaries, so there was again no clear relation between this covariate and the effect of race on mortality.
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Discussion
Disparities in transplant-related outcomes have been reported predominately in renal transplantation based upon a number of recipient and donor factors. 10, 11 Recipient factors contributing to disparate outcomes are often attributed to socioeconomic disadvantage and physiologic or immunologic issues. 12 Blacks, who comprise approximately 13% of the population, have a disproportionately high prevalence of congestive heart failure, often associated with comorbid illnesses such as diabetes mellitus, hypertension, and renal insufficiency. 13 Not only is heart failure more prevalent in blacks, it is also commonly diagnosed at a younger age and may be less responsive to currently utilized heart failure therapies. [14] [15] [16] The p=0.003). Blacks had higher rates of postoperative drug-treated infection (black ks s s 26 26 6.5 5 5% % % ve ve vers rs r us u whites 23.5% versus Hispanics 23.9%; p=0.04). Rates of drug-treated rejection in the first e po ost st stop op ope er erat at ativ iv ive e e ye ear ar ar w were also higher in blacks (bl bl lac a a k k ks 34.9% versu su us s wh wh hit it ite e es 30.8% versus H Hisp p spanics 29.6 6% %; % p p<0 <0 <0.0 001 01 01) ). ).
limited number of suitable donor heart organs (approximately 2,000 per year) and the persistent supply-to-demand imbalance underscores the need to understand the risks, benefits and outcomes of transplantation in various patient groups.
Blacks have more advanced heart failure (represented by a higher percentage of UNOS status 1A) at a younger age when being considered for transplant. 2 If black patients are less optimally treated for advanced heart failure, theoretically this could negatively impact immediate and long-term outcomes after transplant. Similarly, access to medical therapy before and after transplantation, socioeconomic status, dietary habits, pharmacokinetics, and genetic expression and polymorphisms could all potentially impact outcomes in blacks with advanced heart failure after transplantation.
Recipient Race and Mortality After OHT
Recipient race has been shown to be a significant risk factor for mortality after OHT. A UNOS study of over 21,000 OHT patients transplanted between 1999-2008 found that blacks, but not other races, were at increased risk of 1-year mortality as compared to whites after riskadjustment. 6 Another UNOS analysis demonstrated that blacks had an 11.4% absolute decrease in 10-year survival compared to whites, and a 46% increased risk of cumulative mortality after risk-adjustment. 5 A study spanning 22 years and over 39,000 patients found that although mortality decreased over time for all races, the disparity in mortality between blacks and whites remained unchanged. 1 In our analysis, we similarly found that blacks but not Hispanics had higher unadjusted and risk-adjusted 1-year mortality relative to white recipients.
Immunologic Factors Contributing to Increased Mortality in Black OHT Recipients
With the outcomes gap between blacks and other races in OHT being well established, the question arises as to why this gap exists. One potential explanation may relate to immunologic after transplantation.
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differences. A study of 19,000 OHT recipients found that blacks had higher peak panel reactive antibody levels and were more likely to be sensitized than other races. 4 Not unexpectedly, blacks were more likely to experience graft failure in their analysis.
Another multi-institutional study found that black race was a strong risk factor for late rejection after OHT, with the recommendation that endomyocardial biopsy surveillance be continued beyond the first post-transplant year in higher risk cohorts including blacks as a means to reduce the odds of mortality. 17 Moreover, a large-cohort analysis found that blacks were more likely to die of graft failure than white patients but less likely to die of malignancy or infection, again supporting the notion of racial differences in immunologic activity in this clinical setting. 1 In fact, multiple groups have tailored immunosuppressive strategies in black recipients due to the higher risk of allograft rejection and the varying efficacies and pharmokinetics of different regimens unique to this population. 18 More specifically, tacrolimus-treated blacks were found to have improved freedom from allograft rejection at 1-year and improved 1-year survival with no difference in infection rates as compared to cyclosporine-treated blacks, with the latter having higher rates of hyperlipidemia and hypertension than the former. 18 In our analysis, blacks had higher rates of postoperative infection and drug-treated rejection in the first postoperative year again suggesting a potential immunologic basis for the higher mortality in this cohort.
Other Factors that May Contribute to Increased Mortality in Black OHT Recipients
In addition to potential immunologic factors contributing to the differences in mortality rates after OHT between races, there are other non-immunologic factors that may contribute as well.
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States Census Bureau reported in 2013 that 31.9% of black adults were married compared to 45.3% of Hispanics and 53.3% of whites. 19 Married patients have been shown to have improved 1-and 5-year survival after OHT as compared to unmarried patients. 20 Furthermore, although blacks constitute 13% of the American population, a disproportionately higher percentage (approximately 22%) of Medicaid recipients are black. 21 In turn, patients with Medicaid are at higher risk of long-term mortality after OHT as compared to self-pay recipients or those with private insurance. 22 It is certainly important to acknowledge that analyses of race and its impact on mortality should control for these potential confounders although often this is not possible due to limitations of the study design or the database used. Of interest, although we could not evaluate overall rates of medication and surveillance noncompliance, a higher proportion of deaths were due to noncompliance in blacks and Hispanics as compared to whites as reported by transplant centers. This finding merits further investigation in future studies.
Study Rationale and Findings
In addition to immunologic and socioeconomic variables contributing to the effect of race on mortality, there are also systems-related issues that may have a significant impact. OHT is unique to other cardiac operations such as coronary artery bypass grafting or valve procedures because the annual number of OHTs is limited by the donor supply and as a consequence has remained stable over the last decade. 23 Therefore, with a relatively fixed number of OHTs, unique issues arise and have been debated such as which recipients should be prioritized in receiving a transplant and which centers should perform the transplants.
In this study, we evaluated whether minorities had increased propensity to be transplanted at centers with higher than expected mortality. An important finding was that black patients, but not Hispanics, were at a higher likelihood of undergoing their OHT at worse evaluate overall rates of medication and surveillance noncompliance, a higher pro ro opo po ort tio io on n n of of of deaths were due to noncompliance in blacks and Hispanics as compared to whites as reported by r ran an nsp sp spla la lant nt nt c c cen en nters rs rs. . T This finding merits further in n nve ve v s stigation in fut ut tur u u e st st tud ud udies. n
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We evaluated the performance of each center using OE ratios. Importantly, because black race itself is a significant risk factor for mortality after OHT, it was essential to include this in the calculation of the center's expected mortality. Even after taking this difference in recipient risk as well as differences in donor risk into account, it was evident that a higher proportion of blacks were transplanted at centers that performed worse than projected. In fact, the majority of black recipients (56%) were transplanted at centers with an OE ratio greater than 1, whereas the majority of whites and Hispanics were transplanted at centers with ratios less than 1. Although we could not control for all socioeconomic variables that may influence survival as previously mentioned, we were able to control for primary insurance type and highest education level, and our findings persisted after risk adjustment. Additionally, we demonstrated a modest but statistically significant correlation between proportion of recipients that were black at a given center and that center's observed to expected mortality. In other words, centers that had a higher percentage of black recipients also had increasingly higher than projected mortality rates.
Study Implications
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insurance status had a significant impact amongst these additional variables. The lack of difference in outcomes in the Hispanic cohort provides some support for the contribution of genetic heterogeneity, which is higher in black recipients, and weighs against a dominant contribution of the socioeconomic challenges. These collective findings reflect the underlying complexity of the relationship between recipient race and outcomes of OHT, with no clear predominant etiology as to the discrepancies that exist.
To our knowledge, this is the first study to demonstrate a significant propensity of blacks to be transplanted at worse performing heart transplant centers. Although simply referring blacks to better performing centers would result in an improvement in absolute survival, this
would not likely eliminate the racial disparities that exist in outcomes of OHT as blacks still appear to be at increased risk for mortality even in excellent performing centers. Furthermore, the decision of which center to be transplanted at from an OHT candidate's standpoint relates to many factors beyond outcomes at that center. Given the medication and surveillance requirements and the clinical follow-up that is necessary particularly in the first year after OHT, relocating or serially visiting another transplant center is simply not possible for many patients.
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which of these processes of care leads to worse outcomes at these centers, resources can be provided and measures can be taken to improve the overall performance at that center.
Implementation of clinical guidelines for transplant centers could have a positive impact on disparities and outcomes similar to what has been observed with the American Heart Association Get With the Guidelines program for a variety of cardiovascular disease entities.
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Limitations
The primary limitation of our analysis was that it was restricted to variables available in the UNOS registry. We could not account for differences between races with respect to personal or household income, marital status and other social support systems, distance to the nearest transplant center and the availability of other nearby transplant centers, interaction between patients and physicians/systems, or medication compliance although these factors would undoubtedly contribute to outcomes and/or the propensity to be transplanted at a given center.
We also could not account for specific hospital characteristics such as urban versus surburban or rural setting and university versus community status. There may be other variables as well that
were not included in our recipient or donor risk scores or in models used for our analysis that may create the potential for unknown confounding. In addition, one could argue that ethnicity should not be used in the calculation of expected mortality although the format of our data analysis included recipient race as a component of the IMPACT risk index in the calculation of expected mortality. If this variable was not included in the risk adjustment, one may also argue that the higher observed to expected mortality ratios in centers serving higher percentages of black patients could simply be a reflection of higher mortality risk not captured in the expected mortality calculation, therefore creating an artificially higher observed to expected mortality ratio.
ransplant center and the availability of other nearby transplant centers, interactio io on be be b tw tw twee ee een n n patients and physicians/systems, or medication compliance although these factors would un ndo do doub ub ubt te tedl dl dly y y c cont nt ntri ri ribu b te to outcomes and/or the pr pr prop op pensity to be t tra ra ransp pla la lan n nted at a given center.
We We a also could d no no ot ac cc co cou un unt t t fo fo for r r sp spec ec ecif if i ic ic c h h hosp pi ita a al ch h ha ar rac cte te teri rist st tic cs s su su uc ch h a as s ur urba ban n n v ve vers rsu us us s sur ur rbu u u b rb rban an an or u ura ra ral l se se sett ttin in ng g g an and d un n niv ive e ers si sity ty v ve er e su su sus s s c c com om mmu mu muni ni nity y y s s sta ta atu tus s. Th Th her er ere e m ma may y y be be be o ot th the er er v var ar a ia ia iabl bles es es as s w we well ll t t tha a at t <0.001 * Similar findings were observed when blood-type mismatch, human leukocyte mismatch, primary payer status, and education level of the recipient were forced into the model: blacks (OR 1.29, 95% CI 1.10-1.52; p=0.002) but not Hispanics (OR 1.00, 95% CI 0.78-1.28; p=0.99) were at increased risk of 1-year mortality. † The IMPACT score was also a significant predictor of 1-year mortality when recipient race was included and not separately examined (OR 1.13, 95% CI 1.12-1.14; p<0.001). Abbreviations: IMPACT, Index for Mortality Prediction After Cardiac Transplantation; OHT, orthotopic heart transplantation Table 3 . One-year absolute mortality stratified by recipient race and center performance. by guest on July 14, 2017
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